{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T11:54:14Z","timestamp":1765713254543,"version":"3.48.0"},"reference-count":56,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T00:00:00Z","timestamp":1627862400000},"content-version":"unspecified","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C37316\/A29656"],"award-info":[{"award-number":["C37316\/A29656"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,6,30]]},"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Hormone replacement therapy (HRT) can help women experiencing menopausal symptoms, but usage has declined due to uncertainty around risks of cancer and some cardiovascular diseases (CVD). Moreover, improved cancer survival rates mean that more women who survive cancer go on to experience menopausal symptoms. Understanding these relationships is important so that women and their clinicians can make informed decisions around the risks and benefits of HRT. This study\u2019s primary aim is to determine the association between HRT use after cancer diagnosis and the risk of cancer-specific mortality. The secondary aims are to investigate the risks of HRT on subsequent cancer, all-cause mortality and CVD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>We will conduct a population-based longitudinal cohort study of 18\u201379\u2009year-old women diagnosed with cancer between 1998 and 2020, using the QResearch database. The main exposure is HRT use, categorised based on compound, dose and route of administration, and modelled as a time-varying covariate. Analysis of HRT use precancer and postcancer diagnosis will be conducted separately. The primary outcome is cancer-specific mortality, which will be stratified by cancer site. Secondary outcomes include subsequent cancer diagnosis, CVD (including venous thrombo-embolism) and all-cause mortality. Adjustment will be made for key confounders such as age, body mass index, ethnicity, deprivation index, comorbidities, and cancer grade, stage and treatment. Statistical analysis will include descriptive statistics and Cox proportional hazards models to calculate HRs and 95% CIs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethical approval for this project was obtained from the QResearch Scientific Committee (Ref: OX24, project title \u2018Use of hormone replacement therapy and survival from cancer\u2019). This project has been, and will continue to be, supported by patient and public involvement panels. We intend to the submit the findings for peer-reviewed publication in an academic journal and disseminate them to the public through Cancer Research UK.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2020-046701","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T12:24:56Z","timestamp":1627907096000},"page":"e046701","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Hormone replacement therapy and cancer survival: a longitudinal cohort study: protocol paper"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3091-2337","authenticated-orcid":false,"given":"Tom Alan","family":"Ranger","sequence":"first","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Burchardt","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0061-979X","authenticated-orcid":false,"given":"Ashley Kieran","family":"Clift","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6279-4884","authenticated-orcid":false,"given":"Winnie Xue","family":"Mei","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Coupland","sequence":"additional","affiliation":[{"name":"Division of Primary Care, University of Nottingham, Nottingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pui San","family":"Tan","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7469-6093","authenticated-orcid":false,"given":"Sharon","family":"Dixon","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher Robert","family":"Cardwell","sequence":"additional","affiliation":[{"name":"School of Medicine, Dentistry and Biomedical Sciences, Queen\u2019s University Belfast, Belfast, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2479-7283","authenticated-orcid":false,"given":"Julia","family":"Hippisley-Cox","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,8,2]]},"reference":[{"key":"2025121403495096000_11.8.e046701.1","doi-asserted-by":"publisher","DOI":"10.1177\/2053369116680501"},{"key":"2025121403495096000_11.8.e046701.2","doi-asserted-by":"publisher","DOI":"10.4158\/EP.17.6.949"},{"key":"2025121403495096000_11.8.e046701.3","doi-asserted-by":"publisher","DOI":"10.1097\/01.gme.0000243569.70946.9d"},{"key":"2025121403495096000_11.8.e046701.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2014.07.002"},{"key":"2025121403495096000_11.8.e046701.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14065-2"},{"key":"2025121403495096000_11.8.e046701.6","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55090602"},{"key":"2025121403495096000_11.8.e046701.7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.3.321"},{"key":"2025121403495096000_11.8.e046701.8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004143.pub5"},{"key":"2025121403495096000_11.8.e046701.9","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21945"},{"key":"2025121403495096000_11.8.e046701.10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3892\/ol.2016.5424","article-title":"Effects of 17\u03b2-estradiol and tamoxifen on gastric cancer cell proliferation and apoptosis and ER-\u03b136 expression","volume":"13","author":"Wang","year":"2017","journal-title":"Oncol Lett"},{"key":"2025121403495096000_11.8.e046701.11","doi-asserted-by":"publisher","DOI":"10.1111\/dote.12000"},{"key":"2025121403495096000_11.8.e046701.12","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2001.01422.x"},{"key":"2025121403495096000_11.8.e046701.13","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-08-0002"},{"key":"2025121403495096000_11.8.e046701.14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ijsu.2018.03.027","article-title":"Prognostic value of estrogen receptor \u03b1 and estrogen receptor \u03b2 in gastric cancer based on a meta-analysis and the cancer genome atlas (TCGA) datasets","volume":"53","author":"Ge","year":"2018","journal-title":"Int J Surg"},{"key":"2025121403495096000_11.8.e046701.15","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-11-0246"},{"key":"2025121403495096000_11.8.e046701.16","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejca.2017.07.013","article-title":"Sex differences in cancer risk and survival: a Swedish cohort study","volume":"84","author":"Radkiewicz","year":"2017","journal-title":"Eur J Cancer"},{"key":"2025121403495096000_11.8.e046701.17","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1245\/s10434-016-5448-0","article-title":"Sex disparity in gastric cancer: female sex is a poor prognostic factor for advanced gastric cancer","volume":"23","author":"Kim","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"2025121403495096000_11.8.e046701.18","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29960"},{"key":"2025121403495096000_11.8.e046701.19","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.cgh.2017.05.036","article-title":"Estrogen replacement reduces risk and increases survival times of women with hepatocellular carcinoma","volume":"15","author":"Hassan","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025121403495096000_11.8.e046701.20","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejca.2017.07.012","article-title":"Menopausal hormone therapy and cancer risk: an overestimated risk?","volume":"84","author":"Simin","year":"2017","journal-title":"Eur J Cancer"},{"key":"2025121403495096000_11.8.e046701.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)00063-7"},{"key":"2025121403495096000_11.8.e046701.22","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s10654-016-0116-z","article-title":"The influence of hormone therapies on colon and rectal cancer","volume":"31","author":"M\u00f8rch","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"2025121403495096000_11.8.e046701.23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164620","article-title":"Menstrual and reproductive factors and risk of gastric and colorectal cancer in Spain","volume":"11","author":"Lope","year":"2016","journal-title":"PLoS One"},{"key":"2025121403495096000_11.8.e046701.24","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyv097.198","article-title":"Menopausal hormone therapy and risk of central nervous system tumours: a UK-based nested case-control study","volume":"44","author":"Benson","year":"2015","journal-title":"Int J Epidemiol"},{"key":"2025121403495096000_11.8.e046701.25","doi-asserted-by":"crossref","first-page":"e17532","DOI":"10.1097\/MD.0000000000017532","article-title":"Hormone replacement therapy and lung cancer risk in women: a meta-analysis of cohort studies: hormone replacement therapy and lung cancer risk","volume":"98","author":"Jin","year":"2019","journal-title":"Medicine"},{"key":"2025121403495096000_11.8.e046701.26","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3961\/jpmph.15.054","article-title":"Hormonal replacement therapy and the risk of lung cancer in women: an adaptive meta-analysis of cohort studies","volume":"48","author":"Bae","year":"2015","journal-title":"J Prev Med Public Health"},{"key":"2025121403495096000_11.8.e046701.27","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds340"},{"key":"2025121403495096000_11.8.e046701.28","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/aje\/kwy259","article-title":"Reproductive factors, exogenous hormone use, and risk of B-cell non-Hodgkin lymphoma in a cohort of women from the European prospective investigation into cancer and nutrition","volume":"188","author":"Costas","year":"2019","journal-title":"Am J Epidemiol"},{"key":"2025121403495096000_11.8.e046701.29","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24248"},{"key":"2025121403495096000_11.8.e046701.30","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/ijc.28022","article-title":"Reproductive factors and menopausal hormone therapy and bladder cancer risk in the NIH-AARP diet and health study","volume":"133","author":"Daugherty","year":"2013","journal-title":"Int J Cancer"},{"key":"2025121403495096000_11.8.e046701.31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12253-018-00569-x","article-title":"Hormone Replacement Therapy in Cancer Survivors - Review of the Literature","volume":"26","author":"Deli","year":"2020","journal-title":"Pathol Oncol Res"},{"key":"2025121403495096000_11.8.e046701.32","doi-asserted-by":"crossref","DOI":"10.1093\/hropen\/hox007","article-title":"HRT for women with premature ovarian insufficiency: a comprehensive review","volume":"2017","author":"Webber","year":"2017","journal-title":"Hum Reprod Open"},{"key":"2025121403495096000_11.8.e046701.33","first-page":"CD008830","article-title":"Hormone replacement therapy for women previously treated for endometrial cancer","volume":"5","author":"Edey","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121403495096000_11.8.e046701.34","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/ijc.31228","article-title":"Use of hormone replacement therapy improves the prognosis in patients with colorectal cancer: a population-based study in Sweden","volume":"142","author":"Ji","year":"2018","journal-title":"Int J Cancer"},{"key":"2025121403495096000_11.8.e046701.35","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.0580"},{"key":"2025121403495096000_11.8.e046701.36","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-6428-0","article-title":"Association of hormone replacement therapy with mortality in colorectal cancer survivor: a systematic review and meta-analysis","volume":"19","author":"Jang","year":"2019","journal-title":"BMC Cancer"},{"key":"2025121403495096000_11.8.e046701.37","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601595"},{"key":"2025121403495096000_11.8.e046701.38","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.ijrobp.2017.07.016","article-title":"Breast cancer risk after radiation therapy for Hodgkin lymphoma: influence of gonadal hormone exposure","volume":"99","author":"Krul","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025121403495096000_11.8.e046701.39","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/13697137.2017.1309382","article-title":"Hormone therapy for premature ovarian insufficiency patients with malignant hematologic diseases","volume":"20","author":"Yang","year":"2017","journal-title":"Climacteric"},{"key":"2025121403495096000_11.8.e046701.40","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0140-6736(09)61571-3","article-title":"Another nail in the coffin for hormone-replacement therapy?","volume":"374","author":"Ganti","year":"2009","journal-title":"Lancet"},{"key":"2025121403495096000_11.8.e046701.41","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.maturitas.2003.09.031","article-title":"Hormone replacement therapy in cancer survivors","volume":"48","author":"Biglia","year":"2004","journal-title":"Maturitas"},{"key":"2025121403495096000_11.8.e046701.42","doi-asserted-by":"publisher","DOI":"10.4158\/EP171828.PS"},{"key":"2025121403495096000_11.8.e046701.43","unstructured":"National Institute for Health and Care Excellence . Menopause: diagnosis and management, 2019."},{"key":"2025121403495096000_11.8.e046701.44","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a1190"},{"key":"2025121403495096000_11.8.e046701.45","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmy039"},{"key":"2025121403495096000_11.8.e046701.46","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-020738"},{"key":"2025121403495096000_11.8.e046701.47","first-page":"49","article-title":"QRESEARCH: a new general practice database for research","volume":"12","author":"Hippisley-Cox","year":"2004","journal-title":"Inform Prim Care"},{"key":"2025121403495096000_11.8.e046701.48","unstructured":"British Medical Association Joint Formulary Committee Pharmaceutical Society (Great Britain) . British National formulary: pharmaceutical PR, 2003."},{"key":"2025121403495096000_11.8.e046701.49","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k4810"},{"key":"2025121403495096000_11.8.e046701.50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232844","article-title":"Cancer morbidity trends and regional differences in England-A Bayesian analysis","volume":"15","author":"Ar\u0131k","year":"2020","journal-title":"PLoS One"},{"key":"2025121403495096000_11.8.e046701.51","unstructured":"Public Health England . Linking treatment tables - chemotherapy, tumour resections and radiotherapy. 58. 4.4 ed. Cancer Research UK - Public Health England, 2018."},{"key":"2025121403495096000_11.8.e046701.52","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0788"},{"key":"2025121403495096000_11.8.e046701.53","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4067"},{"key":"2025121403495096000_11.8.e046701.54","unstructured":"Rubin DB . Multiple imputation for nonresponse in surveys. John Wiley & Sons, 2004."},{"key":"2025121403495096000_11.8.e046701.55","unstructured":"Registries UKaIAoC . UKIACR: performance indicators 2018 report, 2018."},{"key":"2025121403495096000_11.8.e046701.56","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1093\/humrep\/dez222","article-title":"Hormone replacement therapy and the risk of melanoma in post-menopausal women","volume":"34","author":"Hicks","year":"2019","journal-title":"Hum Reprod"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-046701","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T11:49:59Z","timestamp":1765712999000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-046701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":56,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8,2]]},"published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10.1136\/bmjopen-2020-046701"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-046701","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2021,8]]}}}